Hautver?nderungen bei malignen h?matologischen Erkrankungen

详细信息    查看全文

• 作者：Prof. Dr. M. Schmid-Wendtner ; T. Hornung ; M. Meurer ; C.-M. Wendtner
• 关键词：H?matologische Neoplasien ; Neutrophile Dermatosen ; Paraneoplastische Syndrome ; Purpura ; Vaskulitis ; Hematologic neoplasms ; Neutrophilic dermatoses ; Paraneoplasic syndromes ; Purpura ; Vasculitis
• 刊名：Der Hautarzt
• 出版年：2015
• 出版时间：August 2015
• 年：2015
• 卷：66
• 期：8
• 页码：625-635
• 全文大小：948 KB
• 参考文献：1.Cardet JC, Akin C, Lee MJ (2013) Mastocytosis: update on pharmacotherapy and future directions. Expert Opin Pharmacother 14:2033-045PubMed Central PubMed View Article
  2.Prandonie P, Lensing AW, Buller HR et al (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Eng J Med 327:1128-133View Article
  3.Lee AY (2002) Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev 28:137-40PubMed View Article
  4.El Tal AK, Tannous Z (2008) Cutaneous vascular disorders associated with internal malignancy. Dermatol Clin 26:45-7PubMed View Article
  5.Kurzrock R, Cohen PR (1993) Vasculitis and cancer. Clin Dermatol 11:175-87PubMed View Article
  6.Barzilai A, Goldberg SD, Yacob-Hirsch Y et al (1999) Insect bite-like reaction in patients with hematologic malignant neoplasms. Arch Dermatol 135:1503-507PubMed View Article
  7.Schmid-Wendtner MH, Sander C, Volkenandt M, Wendtner CM (1999) Unusual manifestations of B-cell disorders. J Clin Oncol 17:1084-085PubMed
  8.Weisshaar E, Weiss M, Mettang T et al (2015) Paraneoplastic itch: an expert position statement form the Special Interest Group (SIG) of the International Forum of the Study of Itch (IFSI). Acta Derm Venereol 95:261-65PubMed View Article
  9.Johannesdottir SA, Farkas DK, Vinding GR et al (2014) Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol 171:839-46PubMed View Article
  10.Cedeno-Laurent F, Singer EM, Wysocka M et al (2015) Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol 158:1-PubMed View Article
  11.Vannucchi AM, Antonioli E, Guglielmelli P et al (2007) Clinical profile of homozygous JAK2617V >F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840-46PubMed View Article
  12.Lotts T, St?nder S (2014) Research in practice: substance P antagonism in chronic pruritus. J Dtsch Dermatol Ges 12:557-59PubMed
  13.Rauh G, Gresser U, Meurer M, D?rfler H (1989) Sweet-Syndrom bei chronisch myeloischer Leuk?mie. Klin Wochenschrift 67:506-10View Article
  14.Fett DL, Gibson LE, Su WP (1995) Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70:234-40PubMed View Article
  15.Wenning RH, Mehrany K (2008) Dermal and pannicular manifestations of internal malignancy. Deramtol Clin 26:31-3View Article
  16.Wollina U, Haroske G (2011) Pyoderma gangraenosum. Curr Opin Rheumatol 23:50-6PubMed View Article
  17.Su WP, David MD, Weening RH (2004) Pyoderma gangrenosum: clinicopathologic criteria. Int J Dermatol 43:790-00PubMed View Article
  18.Braun-Falco M, Ruzicka T (2011) Skin manifestations in autoinflammatory syndromes. J Dtsch Dermatol Ges 9:232-46PubMed
  19.Schedel J, Bach B, Kümmerle-Deschner JB, K?tter I (2011) Autoinflammatorische Syndrome/Fiebersyndrome. Hautarzt 62:389-01PubMed View Article
  20.Simon A, Asli B, Braun-Falco M (2013) Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy 68:562-68PubMed View Article
  
• 作者单位：Prof. Dr. M. Schmid-Wendtner (1)
  T. Hornung (2)
  M. Meurer (3)
  C.-M. Wendtner (4)
  
  1. Interdisziplin?res Onkologisches Zentrum (IOZ) München, Nu?baumstr. 12, 80336, München, Deutschland
  2. Klinik und Poliklinik für Dermatologie und Allergologie, Universit?tsklinikum Bonn, Bonn, Deutschland
  3. Stiftung zur F?rderung der Hochschulmedizin, Dresden, Deutschland
  4. Klinik für H?matologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing, München, Deutschland
  
• 刊物主题：Dermatology; Immunology; Allergology; Proctology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-1173

文摘

Numerous cutaneous manifestations have been reported in patients with hematologic malignancies. This review provides an overview on this subject by dividing skin lesions into three main groups: (1) skin disorders due to vascular changes (dilatation, occlusion and inflammation), (2) unspecific (e.g. paleness, opportunistic infections) and specific skin lesions (e.g. leukemia cutis), and (3) the large group of paraneoplastic skin disorders. Emphasis is placed on clinical findings and therapeutic options of those paraneoplastic syndromes that are most frequently found in hematologic malignancies.